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Differential Requirement for Caspase 9
in Apoptotic Pathways In Vivo
an antiapoptotic gene (Hengartner, 1996). Several mam-
malian homologs of CED-3, CED-4, and CED-9 have
been identified. Apaf1 is homologous to CED-4 (Zou et
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David Kagi,*² Wilson Khoo,*² CED-9 (Reed, 1994); and at least 11 mammalian cysteine
Julia Potter,*² Ritsuko Yoshida,*² proteases (ªcaspasesº) are homologous to CED-3 (Co-
Stephen A. Kaufman,‖ Scott W. Lowe,§ hen, 1997). The caspases are present in cells as inactive
Josef M. Penninger,*² and Tak W. Mak*²# proenzymes that are activated after their processing
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Toronto, Ontario M5G 2C1 There is recent evidence that caspase function may
Canada be modulated by physical interaction with Apaf1, cyto-
³Samuel Lunenfeld Research Institute chrome c (Apaf2), and Bcl2 family members (Zou et al.,
Program in Molecular Biology and Cancer 1997; Hu et al., 1998; Pan et al., 1998). Caspase 9
Mount Sinai Hospital (Casp9)/Apaf3, a 45 kDa protein ªalso known as ICE-
Toronto, Ontario M5G 1X5 LAP-6 or Mch6º (Duan et al., 1996; Srinivasula et al.,
Canada 1996), forms a multiprotein complex containing Apaf1
§Cold Spring Harbor Laboratory and cytochrome c (Li et al., 1997b). It has been proposed
Cold Spring Harbor that cytochrome c initiates apoptosis by inducing the
New York, New York 11724 formation of the Casp9/Apaf1 complex. Physical associ-‖Amgen Inc.
ation of Casp9 and Apaf1 is mediated by the interaction
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of their respective caspase recruitment domain (CARD)
(Li et al., 1997b). CARD is also found in other caspases
with large prodomains, such as Casp4 and Casp8, which
Summary can associate with Apaf1 in mammalian cells (Hu et al.,
1998). The antiapoptotic protein Bcl-XL has also beenMutation of Caspase 9 (Casp9) results in embryonic
shown to interact with Casp9 and Apaf1, resulting in thelethality and defective brain development associated
inhibition of Casp9 activation (Hu et al., 1998; Pan et al.,with decreased apoptosis. Casp9 2/2 embryonic stem
1998). The association of Casp9 with antiapoptotic ascells and embryonic fibroblasts are resistant to sev-
well as proapoptotic proteins suggests a major role foreral apoptotic stimuli, including UV and g irradiation.
Casp9 in the control of apoptosis in vivo.Casp92/2 thymocytes are also resistant to dexametha-
Since some caspases sequentially process and acti-sone- and g irradiation±induced apoptosis, but are
vate others, a model has been proposed in which somesurprisingly sensitive to apoptosis induced by UV
caspases (such as Casp8 and -9) act as initiator or sig-irradiation or anti-CD95. Resistance to apoptosis is
naling proteases, while others (such as Casp3 and -7)accompanied by retention of the mitochondrial mem-
act as effectors of apoptosis (Cohen, 1997). Casp32/2brane potential in mutant cells. In addition, cytochrome
mice have revealed that Casp3 is required for PCD inc is translocated to the cytosol of Casp92/2 ES cells
the central nervous system (CNS) and also in other apo-upon UV stimulation, suggesting that Casp9 acts
ptotic settings (Kuida et al., 1996; Woo et al., 1998).downstream of cytochrome c. Caspase processing is
Casp3 is also essential for the nuclear changes associ-inhibited in Casp92/2 ES cells but not in thymocytes
ated with apoptosis, including chromatin condensationor splenocytes. Comparison of the requirement for
(Woo et al., 1998).Casp9 and Casp3 in different apoptotic settings indi-
To investigate the physiological function of Casp9,cates the existence of at least four different apoptotic
gene targeting was used to generate mutant cell linespathways in mammalian cells.
and mice deficient for Casp9. We report that Casp9
Introduction deficiency leads to defective brain development and
embryonic lethality. Embryonic stem cells (ES), as well
Apoptosis, or programmed cell death (PCD), is an intri- as mouse embryonic fibroblasts (MEF), are resistant to
cately regulated process (White, 1993; Green and Mar- UV and g irradiation, as well as several other stimuli.
tin, 1995; Steller, 1995; Nagata, 1997). Genetic studies Casp9±deficient thymocytes are resistant to dexameth-
of apoptosis in Caenorhabditis elegans have identified asone and g irradiation but are sensitive to UV irradiation
ced-3 and ced-4 as proapoptotic genes and ced-9 as and a-CD95 killing. Our results identify four distinct
apoptotic pathways differentially utilized by various cell
types in response to different apoptotic stimuli.# To whom correspondence should be addressed.
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Figure 1. Gene Targeting of the Murine Casp9 Locus
(A) Restriction map of genomic Casp9 sequences and the targeting vector. The Casp9 exons replaced by neomycin in the targeted locus are
shown as filled boxes. The Casp9 flanking probe used for Southern blotting is indicated. E, EcoRI; H, HindIII; Sp, SpeI.
(B) Southern blot analysis of genomic DNA derived from wild-type, Casp91/2, and Casp92/2 ES cells (left panel) and E15.5 embryos (right
panel). DNA was digested with SpeI and hybridized with the flanking probe. Arrows point to the 10.7 kb wild type (wt) and the 4.9 kb mutant
(mt) bands.
(C) Western blot analysis of proteins extracted from Casp91/2 (1/2) and Casp92/2 (2/2) ES cells. Incubation with a-Casp9 antisera reveals
the presence of the 45 kDa Casp9 protein in (1/2) ES cells but not in (2/2) ES cells.
(D) Northern blot analysis of total RNA extracted from E7, E11, E15, and E17 embryos and from different adult tissues. Hybridization was
performed using 32P-labeled Casp9 cDNA.
(E) Examples of postnatal day 1 (pnd 1) wild-type (left) and Casp92/2 (right) mice. (F) E15.5 wild-type embryo (left) and two Casp92/2 mutant
mice. (G) E12.5 wild-type embryo (left) and three Casp92/2 embryos showing the variable severity of the mutant phenotype. Arrows point to
the characteristic perturbation of brain structure observed in the mutants. Bar represents 4 mm in (E), 3 mm in (F), and 600 mm in (G).
Results apoptosis, double knockout ES cell lines were gener-
ated by culturing Casp91/2 cells at an increased concen-
tration of G418. Casp92/2 ES clones were obtained andGeneration of Caspase 92/2 Mutant Mice
Casp91/2 ES cells were generated by homologous re- confirmed by Southern blot and Western blot analyses
(Figures 1B and 1C).combination, using a targeting vector designed to delete
2.6 kb of genomic DNA containing three coding exons
of Casp9. This strategy led to the introduction of termi-
Caspase 9 Expression during Embryogenesis
nation codons into all three reading frames and the re- and in Adult Tissues
moval of 138 amino acids, including the key pentapep-
Northern blot analysis using a murine Casp9 probe re-
tide QACGG, required for Casp9 activity (Duan et al.,
vealed the expression of a single Casp9 transcript of
1996) (Figure 1A). When the Casp9 targeting construct
about 4 kb in E7, E11, E15, and E17 embryos (Figure
was electroporated into ES cells, two G418-resistant
1D). However, an additional 2.4 kb transcript, possibly
colonies heterozygousat the Casp9 locus wereobtained
the result of alternative splicing of the 4 kb Casp9 tran-
(Figure 1B). These ES clones were used to generate
script, was detected in adult tissues tested, including
chimeric mice, and bothclones successfully contributed
brain and spleen (Figure 1D). RT-PCR analysis was used
to germline transmission. Chimeras were backcrossed
to confirm the expression of Casp9 in ES cells and thy-
to C57BL/6J or CD1 mice, and Casp9 heterozygotes
mocytes (data not shown). Thus, Casp9 is expressed
were intercrossed to produce homozygous mutant off-
early in embryogenesis and ubiquitously in adult tissues.
spring. The genotypes of the mice were confirmed by
Southern blot analysis (Figure 1B). Homozygotes de-
rived from both Casp91/2 clones had similar phenotypes Caspase 9 Mutation Results in Embryonic Lethality
Interbreeding of Casp91/2 mice showed that homozy-in 129/C57BL/6 and 129/CD1 genetic backgrounds.
To study the effect of Casp9 deficiency on ES cell gosity for the Casp9 mutation was lethal, since fewer
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Table 1. Genotypic and Phenotypic Analysis of Newborn Mice and Embryos from Caspase 9 Heterozygous Intercrosses
Phenotype Genotype
Stage Normal Abnormal Casp91/1 Casp91/2 Casp92/2 Total
Pnd 1 93 7 22 71 7 100
E15.5 23 8 6 17 8 31
E12.5 29 8 9 20 8 37
E10.5 13 0 3 7 3 13
Postnatal day 1 (pnd 1) mice and embryos were genotyped by PCR and Southern blot, as shown in Figure 1B. The embryos were collected
on day 10.5, 12.5, and 15.5 of pregnancy from Casp91/2 females crossed to Casp91/2 heterozygous males. The abnormal phenotype of the
newborn mice and embryos consisted in the perturbation of their brain structure and morphology, as shown in Figures 1E±1G. The mutant
phenotype was similar in 129/C57BL/6 and 129/CD1 genetic backgrounds.
than 8% of postnatal day (pnd) 1 mice were homozy- 2K±2N, and not shown). Thus, Casp9, like Casp3, is
required for PCD during brain development.gotes (Table 1). At birth, Casp92/2 mice were consis-
tently smaller than control littermates, and most died
before pnd 3 (Figure 1E). Timed matings indicated that
Impaired Apoptosis in Caspase 92/2 ES Cellsthe onset of abnormalities was at about E12.5 (Figure
in Response to a Wide Range1G). At E12.5 and E15.5, Casp92/2 mice displayed pro-
of Apoptotic Stimulitrusions of the brain tissue from the skull (Figures 1F
The effect of the Casp9 mutation on apoptosis was fur-and 1G). These data show that Casp9 is required for
ther accessed by comparative studies of two indepen-embryonic and postnatal survival.
dent Casp92/2 ES cell clones, wild-type and Casp32/2
ES cell lines. Casp92/2 ES cells were resistant to all
Caspase 9 Mutation Leads to a Defect apoptotic stimuli tested, including adriamycin, UV and
in Cortex and Forebrain Structures g irradiation, etoposide, sorbitol, cisplatinum, and aniso-
Casp92/2 newborn mice exhibited a striking perturba- mycin (Figure 3A, and not shown). Analysis of apopto-
tion in cortical morphology (Figures 2A and 2B), reminis- tic features of the rare Casp92/2 ES cells that died fol-
cent of that observed in Casp32/2 mice (Kuida et al., lowing UV irradiation showed the expected changes in
1996, and not shown). Examination of pnd 1 Casp92/2 phosphatidyl serine (PS) on the plasma membrane, as
animals revealed gross perturbations of brain structure detected by Annexin V-FITC staining. However, like
that were most severe within the cortex and forebrain. Casp32/2 ES cells, Casp92/2 ES cells that died following
Sites of ectopic cortical growth (Figure 2D, asterisk) and UV irradiation showed incomplete chromatin condensa-
a lack of commissural structures were also frequently tion, as judged by DAPI staining and electron micros-
observed in these animals. Casp92/2 animals exhibited copy (EM) (Figure 3B, and not shown).
a significant expansion of their ventricular zone. In addi-
tion, there was a gross disorganization of ventricular
structure, with the lateral ventricles frequently becoming Requirement of Caspase 9 in MEFs for PCD
in Response to Some, but Not All,contiguous with the subdural space through disruptions
in the dorsal cortex (Figure 2D). Intracerebral hemor- Apoptotic Stimuli
We next examined apoptosis in MEFs. Casp92/2 MEFs,rhage in postnatal Casp92/2 animals was also a common
finding. Casp92/2 animals also exhibited accumulations like Casp32/2 MEFs, were resistant to apoptosis induced
by UV and g irradiation, adriamycin, and etoposideof necrotic and occasionally ectopic tissue outside the
skull proper, particularly along the anterior aspect of the (Figure 3C, and not shown). To extend these analyses,
MEFs were transformed with E1A/ras oncogenes to in-cerebral hemispheres (Figure 2B). Within these regions,
the bone matrix was discontinuous and grew around crease their sensitivity to several apoptotic stimuli, in-
cluding g irradiation, mTNF-a, and chemotherapeuticthese masses, suggesting that they occurred relatively
early in the course of cranial development. drugs. Transformed Casp92/2 MEFs remained resistant
to adriamycin but underwent apoptosis in response toTo understand the origin of the morphological disrup-
tions observed in the Casp92/2 mutants, we examined mouse TNF-a treatment (Figure 3D), showing normal
apoptotic features including chromatin condensationPCD during the embryonic development of these ani-
mals. Examination of E12.5 embryos by TUNEL labeling and DNA degradation (Figure 3E, and not shown). Con-
sistent with these data, Casp92/2 primary MEFs tran-demonstrated substantially less cell death within the
developing CNS of Casp92/2 embryos compared to con- siently transfected with a TNF-R1 expression vector
succumbed to apoptosis (Figure 3C). Furthermore, stud-trol littermates. As shown in Figures 2H and 2J, signifi-
cant reductions in PCD were observed in the mutant in ies of Casp92/2 MEFs as target for cytotoxic T lympho-
cytes indicated that Casp9, like Casp3 (Woo et al., 1998),both the cerebral cortex and trigeminal ganglion at this
stage. However, no difference in PCD was observed is not required for CTL target cell lysis mediated via the
perforin/granzyme pathway (not shown).between Casp91/2 and Casp92/2 embryos at other sites
such as brain-associated mesenchymal tissue (not To demonstrate that the apoptotic defects of the
Casp92/2 MEFs were a direct consequence of Casp9shown). The number of BrdU-positive cells at E12.5 and
E15.5 was also consistently increased over controls deficiency, a wild-type human CASP9 gene was reintro-
duced into E1A/ras MEFs by retroviral gene transfer.within the ventricular zone of Casp92/2 embryos (Figures
Cell
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Upon treatment with adriamycin, Casp92/2 MEFs ex- Caspase 9 Is Required for Splenocyte Apoptosis
in Response to g Irradiationpressing exogenously transfected Casp9 died at levels
similar to wild-type controls (not shown). Like Casp92/2 thymocytes, Casp92/2 splenocytes were
resistant to g irradiation (Figure 4B). However, Casp9These results demonstrate that, in MEFs, Casp9 is
not necessary for the TNF-induced pathway of apopto- deficiency did not protect splenocytes from several
other apoptotic stimuli, including UV irradiation, sorbi-sis, nor for CTL target cell lysis mediated via the perforin/
granzyme pathway, but that apoptotic pathways in- tol-induced osmotic shock, and several chemothera-
peutic drugs, such as adriamycin, etoposide, and cis-duced by other stimuli require Casp9 expression.
platinum (Figure 4B, and not shown). As shown in Figure
4B, Casp3 deficiency did not rescue splenocytes fromNormal Development of Thymocytes
and Lymphocytes in the Absence PCD induced by UV or g irradiation. However, we have
previously shown that Casp3 is required for apoptoticof Caspase 9
To determine the role of Casp9 during the development morphological changes in lymphocytes following UV
and g irradiation (Woo et al., 1998).and PCD of thymocytes and lymphocytes, we analyzed
these cells in Casp92/2 pnd 2 mice, as well as those in Casp9±deficient splenocytes that did die in response
to UV or g irradiation showed normal PS plasma mem-Casp92/2; Rag22/2 somatic chimeric mice. Thymocyte
numbers were similar in Casp92/2 and Casp91/2 pnd 2 brane changes but aberrant chromatin condensation,
as assessed by DAPI staining (Figures 4B and 4E). Thus,mice (12.7 3 106 6 2 and 14.9 3 106 6 1.6, respectively;
n 5 2). Similarly, numbers of thymocytes obtained from Casp9 function is essential for the g irradiation±induced
cell death of splenocytes and the completion of chroma-6-week-old Casp92/2; Rag22/2 and Casp91/2; Rag22/2
chimeric mice were comparable (143 3 106 6 84 and tin condensation in response to a range of apoptotic
signals, including UV and g irradiation.110 3 106 6 65, respectively; n 5 6), as were numbers
of splenocytes (78 3 106 6 15 and 70.7 3 106 6 19,
respectively; n 5 6). However, lymph nodes (LN) of Caspase 9 and Apoptosis of Activated Splenocytes
The PCD of activated splenocytes lacking Casp9 was6-week-old reconstituted Casp92/2; Rag22/2 chimeric
mice were consistently enlarged compared to those in analyzed in response to a-CD95 or a-CD3e antibodies.
While activated Casp32/2 lymphocytes were resistantCasp91/2; Rag22/2 controls (99.4 3 106 6 10.4 and
50.5 3 106 6 9.7, respectively; n 5 6). Flow cytometric to PCD induced by these stimuli (Woo et al., 1998),
dose±response and time course analysis indicated thatanalysis showed no significant differences in the per-
centages of various thymocyte, splenocyte, and LN sub- Casp92/2 cellswere completely sensitive to these stimuli
and showed normal apoptotic features, including PSpopulations present in Casp92/2 mice as compared with
controls (not shown). plasma membrane changes as well as chromatin con-
densation (Figures 4C and 4E, and not shown). Further-
more, activation-induced cell death (AICD) was not af-Requirement of Caspase 9 for Thymocyte
Apoptosis in Response to g Irradiation fected in the absence of Casp9 (not shown).
Thus, unlike Casp3, Casp9 is required for neither AICDand Dexamethasone
Apoptosis was assayed in Casp92/2, Casp32/2, and nor for the a-CD3± or a-CD95±mediated apoptosis of
activated splenocytes.wild-type thymocytes in response to a variety of apo-
ptotic stimuli. Casp92/2 thymocytes, but not Casp32/2
or wild-type thymocytes, were resistant to apoptosis Caspase 9 Mutation Affects Mitochondrial
Membrane Potentialinduced by dexamethasone or g irradiation (Figure 4A).
Furthermore, Casp92/2 thymocytes showed resistance Apoptosis is always accompanied by a decrease inmito-
chondrial membrane potential (Dcm) (Mignotte andto etoposide-induced PCD, but not to apoptosis in-
duced by a-CD95, TNF-a, UV irradiation, heat shock, Vayssiere, 1998). Flow cytometric determinations of
DiIC15 were used to visualize time courses of Dcmor sorbitol-induced osmotic shock (Figure 4A, and not
shown). Those Casp92/2 thymocytes that did die after changes in Casp91/2, Casp32/2, and Casp92/2 thymo-
cytes treated with dexamethasone (Figure 5). Interest-treatment with dexamethasone exhibited normal apo-
ptotic features, including changes to PS on the plasma ingly, untreated Casp92/2 thymocytes exhibited a lower
Dcm compared to untreated Casp91/2 and Casp32/2membrane and chromatin condensation (Figures4A and
4D). These data demonstrate that Casp9 is required for cells, indicating a Casp9±dependent defect in the main-
tenance of Dcm in these cells. When treated with dexa-thymocyte apoptosis in response to two major apoptotic
stimuli, dexamethasone and g irradiation. methasone, Casp91/2 and Casp32/2 thymocytes died
Figure 2. Morphology of Caspase 92/2 Mice
Overview of the cranium at pnd 1 of (A) Casp91/2 and (B) Casp 92/2 littermates. The overlying skin has been removed for clarity. (C±F) Thionin-
stained coronal forebrain sections from pnd 1 mice viewed at several levels. (C) and (E), Casp91/2 mice; (D) and (F), Casp92/2 mice. Note the
invasion of the cortical tissue (asterisks) and expansion of the ventricular zone (arrows) in Casp92/2 mice. The cortical disruption observed
in Casp92/2 mice also typically resulted in a lack of commissural structures, such as the corpus callosum (open arrowheads, C and E). (G±J)
TUNEL sections of (G and I) Casp91/2 and (H and J) Casp 92/2 littermates at E12.5. Relative levels of the horizontal forebrain sections (G and
H) and trigeminal ganglion sections (I and J, dotted boundaries) are shown in the inset. At these sites, Casp92/2 embryos exhibit significantly
fewer apoptotic nuclei (arrowheads) than their Casp91/2 littermates. (K±N) BrdU-labeled sections of (K and M) Casp91/2 and (L and N) Casp92/2
littermates at E12.5 (bars represent 150 mm). The relative position of micrographs within the horizontal plane is shown in the inset. At this
age, increased BrdU-positive cells are observed in Casp92/2 mice compared to controls.
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Figure 3. Impaired Apoptosis in Caspase 92/2 ES Cells and MEFs
(A) Induction of apoptosis of Casp92/2 and Casp91/2 cells in response to adriamycin, UV, or g irradiation. Left panels: Cells were treated with
various doses of the indicated stimuli and analyzed 40 hr later by Annexin V-FITC and PI costaining and flow cytometry. Solid bars, Casp91/2;
open bars, Casp92/2. Right panels: Casp91/2 (squares) and Casp92/2 (circles) ES cells were treated with a single dose of adriamycin (0.3 mg/
ml), UV irradiation (80 mJ/cm2), or g irradiation (600 rads) and analyzed at the indicated times by Annexin V and PI staining and flow cytometry.
(B) Electron microscopy of dead wild-type (left) and Casp92/2 (right) ES cells. Cells were treated with UV irradiation (80 mJ/cm2) for 24 hr and
processed for visualization by electron microscopy. Ch, chromatin.
(C) Induction of apoptosis of Casp92/2, Casp32/2, and Casp91/2 primary MEFs. Apoptosis was induced and cells were assayed at the indicated
time points by Annexin V and PI staining and flow cytometry. Left panel: UV irradiation (40 mJ/cm2). Solid bars, untreated (NT); gray bars, 24
hr after treatment; open bars, 48 hr after treatment. Middle panel: Adriamycin (0.3 mg/ml; 20 hr); Etoposide (100 mM; 20 hr). Solid bars, NT;
gray bars, adriamycin (Adr) ; open bars, etoposide. Right panels: Cells were transiently transfected with a GFP expression vector only (NT),
or in combination with a TNF-R1 expression vector (TNF-R1). Twenty-four hours posttransfection, the % of viability (the ratio between the %
of fluorescent cells in the analyzed culture compared to the % of fluorescent cells in the GFP transfected cultures) was determined. Results
of a representative experiment are shown, n 5 3. Solid bars, Casp91/2; open bars, Casp92/2.
(D) Cell death of E1A/Ras-transformed MEFs; Casp91/1 (empty circles) and Casp92/2 (filled circles/dashed lines). Transformed MEFs were
treated with increasing amounts of adriamycin (left upper panel) or mTNF-a (left lower panel) and harvested 24 hr later. E1A/Ras MEFs were
treated with a single dose of adriamycin (0.2 mg/ml; right upper panel) or mTNF-a (50 ng/ml; right lower panel) and collected at the indicated
time points. Cell death was determined by trypan blue exclusion.
(E) Fluorescence microscopic visualization of DAPI staining of nuclear chromatin from wild-type and Casp92/2 transformed MEFs, either
untreated (NT) and attached to the plate, ordead (floating) following 24 hr treatmentwith 0.2 mg/ml of adriamycin (Adr) or 50 ng/ml mTNF-a (TNF).
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Figure 4. Requirement for Caspase 9 for Apoptosis of Thymocytes and Splenocytes in Response to Some, but Not All, Stimuli
(A±C) Fluorescence dot blots of Annexin V- and PI-stained thymocytes, naive or activated splenocytes from Casp91/2; Rag22/2 (Casp91/2),
Casp32/2, or Casp92/2; Rag22/2 (Casp92/2) mice. Cells were either untreated (NT) or treated for 24 hr or 48 hr with dexamethasone (Dex, 1
mM), g irradiation (g, 600 rads), UV irradiation (UV, 40 mJ/cm2), a-CD95 (1 mg/ml), or a-CD3 (1 mg/ml). The percentages of viable cells are
indicated.
(D and E) Fluorescence microscopic visualization of DAPI staining of DNA from (D) Casp91/2 and Casp92/2 thymocytes and (E) splenocytes
either untreated (NT) or treated with dexamethasone, UV, or g irradiation. DAPI staining was also performed on activated splenocytes treated
for 24 hr with a-CD95.
rapidly, and death was accompanied by a total loss Caspase 9 Acts Downstream of Mitochondrial
Cytochrome c Releaseof Dcm. However, Casp92/2 thymocytes treated with
dexamethasone resisted further loss of Dcm and re- Cytochrome c is required for PCD in vivo (Li et al., 1997a;
Zhivotovsky et al., 1998) and for the activation of Casp9tained their (abnormally low) Dcm (Figure 5).
Thus, in addition to its function during thymocyte apo- and -3 in vitro (Kluck et al., 1997; Li et al., 1997b; Yang
et al., 1997; Zou et al., 1997). The release of cytochromeptosis in response to dexamethasone, Casp9 also plays
a role in the regulation Dcm, both in resting thymocytes c from the mitochondria during apoptosis precedes the
changes of Dcm and caspase activation (Bossy et al.,and in thymocytes responding to apoptotic stimuli.
Cell
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Figure 5. Mitochondrial Membrane Potential in the Absence of Caspase 9
Flow cytometric analysis of Dcm and Annexin V staining of Casp91/2; Rag22/2 (Casp91/2), Casp32/2, and Casp92/2; Rag22/2 (Casp92/2)
thymocytes untreated (0 hr) or treated with 1 mM of dexamethasone for 6 or 18 hr. The percentages of the different populations stained
positively for Dcm level and Annexin V are indicated.
1998). Furthermore, it has been shown that mitochon- Caspase 9 Requirement for Caspase
Activation In Vivodrial cytochrome c release, in response to apoptotic
stimuli, is not affected by the pancaspase inhibitor pep- Studies in vitro have suggested that Casp9 is the most
upstream member of the apoptotic protease cascadetide zVAD-fmk (Bossy et al., 1998) or by the apoptotic
inhibitor viral protein p35 (Kharbanda et al., 1997). that is triggered by the interaction of cytochrome c,
Apaf1, and dATP (Li et al., 1997b). We investigated theThe effect of Caspase 9 on cytochrome c release has
been accessed using the Casp9 mutant cells. Following role of Casp9 during the activation of the caspase cas-
cade in a variety of cell types in response to severalUV irradiation, cytochrome c levels in the cytosol of
both Casp92/2 and Casp91/2 ES cells were significantly apoptotic stimuli. In ES cells, in which Casp9 deficiency
resulted in resistance to all stimuli tested, there was aincreased compared to untreated controls, but not sig-
nificantly different from each other (Figure 6A). Cyto- complete absence of procaspase processing (including
pro-Casp3 and -8) following UV irradiation (Figure 6B,chrome c release from mitochondria in Casp92/2 ES
cells and MEFs following UV stimulation was confirmed and not shown). The block in caspase processing was
accompanied by a lack of cleavage of PARP, Rb, andimmunohistochemically, using an a-cytochrome c anti-
body (not shown). Therefore, cytochrome c transloca- the fluorogenic molecule AcDEVD-AMC, a substrate for
Casp3 and Casp3-like caspases (Figure 6C, and nottion to the cytosol of these Casp9±deficient cells in re-
sponse to UV irradiation is not sufficient to trigger their shown). Thus, in ES cells, Casp9 is required for the
activation of the caspase cascade in response to UVPCD. Thus, Casp9 acts downstream of mitochondrial
cytochrome c release. irradiation.
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Figure 6. Cytochrome c Translocation to the Cytosol and Caspase Activation in Casp92/2 Cells
(A) Cytochrome c (Cyt.c) translocation to the cytoplasm in response to UV irradiation. Casp91/2 and Casp92/2 ES cells were treated with UV
irradiation (80 mJ/cm2) and cultured for an additional 6 hr. Cytosolic fractions were prepared from untreated (NT) and treated (UV) cells.
Western blot analyses were performed using a-cytochrome c and anti-b-actin MAbs.
(B) Absence of Casp3 activation in Casp92/2 ES cells. Immunoblots of total proteins from Casp91/2, Casp92/2, and Casp32/2 ES cells 8 hr
after UV irradiation (80 mJ/cm2) were incubated with a-Casp3 and anti-b actin MAbs.
(C) Absence of PARP cleavage in Casp92/2 ES cells. Cells were treated as in (B), and PARP cleavage was assayed with an a-PARP MAb.
The unprocessed form of PARP (113 kDa) as well as the 89 kDa processed form are indicated.
(D) Casp3 processing in activated T cells deficient for Casp9. Splenocytes were either untreated (NT) or activated and stimulated for 24 hr
with a-CD3 (CD3) or a-CD95 (CD95) MAbs. Western blots were performed with an a-Casp3 MAb. Pro-Casp3 (32 kDa) and a processed form
(p17) are indicated.
(E) Casp2, -3, -8, and b-actin in immunoblots of total proteins from Casp91/2, Casp92/2, and Casp32/2 thymocytes 8 hr after either no treatment
(NT), incubation at 378C (37), or treatment with 1 mM dexamethasone (Dex) at 378C. Procaspases as well as their processed forms are indicated.
However, in activated Casp92/2 T cellsstimulated with Emerging evidence indicates that these effects are cell
type± and stimulus-specific.a-CD3e or a-CD95, efficient processing of Casp3 and
Casp8 occurred in both cases (Figure 6D, and not
shown). In Casp92/2 thymocytes treated with dexameth- Caspase 9 and Brain Development
The regulation of apoptosis is crucial for normal devel-asone, pro-Casp2, -3, -7, and -8 underwent processing
to a limited extent (Figure 6E, and not shown). Cleavage opment of the CNS. Mutation of antiapoptotic Bcl2 fam-
ily members, such as Bcl-XL, triggers increased develop-of PARP and Rb was observed in dexamethasone-
treated Casp92/2 thymocytes (not shown). These data mental apoptosis within the CNS, resulting in embryonic
lethality at E13 (Motoyama et al., 1995). In null mutantsindicate that Casp9 is differentially required in different
cell types for caspase processing. of proapoptotic Bcl2 family members such as Bax, the
survival of some neural cells is enhanced (Knudson et
al., 1995; Deckwerth et al., 1996), resulting in a develop-Discussion
mental increase in numbers of sympathetic and facial
motor neurons in these animals. In addition, neuronsApoptosis is essential for normal development. Pertur-
bations of the regulation or execution of developmental from these animals are able to survive growth factor
deprivation or axotomy-induced target deinnervation.PCD usually result in profoundly detrimental effects.
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Caspase activationis known to beregulated by ªinhib- to the immunoglobulin heavy chain locus occurs fre-
quently in human follicular lymphomas (Bakhshi et al.,itor of apoptosisº proteins (IAPs), which inactivate some
caspase family members through direct physical inter- 1985; Tsujimoto et al., 1985). In addition, several tumor
suppressor genes and oncogenes are involved in theaction via the BIR domain (Roy et al., 1997; Deveraux
et al., 1998). In addition, high levels of some IAP family regulation of apoptosis. For example, p53 is required
for cell death induced by different stimuli, including gmembers, such as neural IAP (NIAP), have been shown
to be principally confined to thenervous system neurons irradiation. A lack of p53 in thymocytes results in their
resistance to ionizing irradiation-induced apoptosis(Liston et al., 1996). Taken together, these features attest
to the importance of PCD in regulating the development (Lowe et al., 1993). Both homozygous and heterozygous
p53 mutant mice of advanced age develop a wide rangeof the CNS.
In this study, we have demonstrated that the absence of tumors, including thymomas (Donehower, 1996).
In this study, Casp9 deficiency protected thymocytes,of Casp9 leads to a dramatic disturbance of telence-
phalic development that apparently results from de- splenocytes, MEFs, and ES cells from g irradiation±
induced cell death. Casp91/2 mice at 7 months of agecreased apoptosis in this region. A reduction in PCD
could also account for the increased BrdU-positive cells were healthy, phenotypically normal, and did not show
any sign of tumor formation. However, these mice mayobserved within the germinal zones of Casp92/2 mu-
tants, consistent with the survival of greater numbers develop tumors as they age further. The fact that, like
p53 deficiency, Casp9 deficiency results in resistanceof neuroepithelial progenitors. As a consequence, both
the ventricular zone and forebrain cortical structures to apoptosis induced by g irradiation or a variety of
chemotherapeutic drugs suggests that Casp9 may playare expanded in these mutant mice, disrupting cortical
organization and ultimately resulting in intracranial hem- a role during tumor development or progression.
orrhage and death.
The gross morphological features observed in Casp92/2 Caspase 9± and Caspase 3±Dependent
mice are remarkably similar to those observed in mice Apoptotic Pathway
lacking Casp3 (Kuida et al., 1996). Both mutants exhibit In vitro studies have previously identified Apaf1, cyto-
a profound disturbance of cortical morphology, an ex- chrome c, and Casp9 as participants in a complex im-
panded germinal zone, and hydrocephaly, suggesting portant for Casp3 activation. In vitro depletion of Casp9
that these mutations affect a common cellular apoptotic from cytosolic fractions resulted in the failure of Casp3
pathway dependent on both Casp9 and Casp3. activation (Li et al., 1997b). These findings point to the
existence of an apoptotic pathway dependent on both
Caspase 9 and Thymocyte Development Casp9 and Casp3. The existence of such a pathway in
PCD is a critical process in thymocyte development. vivo was confirmed in our study, since both Casp92/2
Several stimuli are known to induce thymocyte apopto- and Casp32/2 ES cells were resistant to several apo-
sis, including glucocorticoids, CD95 ligation, and UV ptotic signals, including UV irradiation. Those Casp92/2
and g irradiation. Overexpression of Bcl2 in thymocytes ES cells that died in response to UV irradiation showed
results in their resistance to apoptosis induced by dexa- abnormal morphological features reminiscent of Casp3
methasone, a-CD3, or g irradiation, but not by a-CD95 deficiency (Woo et al., 1998). Furthermore, the lack of
(Sentman et al., 1991). Bcl2 has been shown to act at the Casp9 in UV-irradiated ES cells resulted in a blockade
mitochondrial level and upstream of Casp3 activation of the processing of Casp3 as well as other caspases.
(Kluck et al., 1997; Yang et al., 1997). However, Casp32/2 This role of Casp9 in ES cells apparently cannot be
thymocytes remain sensitive to several apoptotic stim- assumed by other caspases, such as Casp8, even
uli, including dexamethasone and g irradiation (Kuida et though Casp8 is expressed in ES cells and is capable
al., 1996; Woo et al., 1998), indicating that in thymocytes of binding to Apaf1 (Hu et al., 1998, and not shown).
the antiapoptotic effect of Bcl2 is Casp3±independent. Thus, in ES cells, UV irradiation preferentially triggers
The involvement of other caspases in thymocyte PCD the activation of an apoptotic pathway involving Casp9
has recently been documented. A study of Casp22/2 and Casp3. Mutation of Casp9 or Casp3 produces simi-
mice revealed that Casp2 is not important for thymocyte lar effects on brain apoptosis and development, sug-
apoptosis (Bergeron et al., 1998). Casp11 has been gesting that the pathway dependent on both Casp9 and
shown to interact with Casp1 and to be essential for its Casp3 is physiologically required for PCD in the devel-
activation (Wang et al., 1998). However, deficiency of
oping brain.
either Casp1 or Casp11 in thymocytes results in partial
resistance to a-CD95 killing, but not to other apoptotic
Caspase 9± and Caspase 3±Independentstimuli (Kuida et al., 1995; Wang et al., 1998). In the
Apoptotic Pathwaypresent study, we show that, like Bcl2 overexpression,
The requirement for Casp9 in apoptosis is cell type± andmutation of Casp9 protects thymocytes from dexameth-
stimulus-specific, indicating the existence of multipleasone- and g irradiation±induced cell death. Thus, we
apoptotic pathways. Although Casp92/2 ES cells werehave identified Casp9 as essential for thymocyte PCD
resistant to a broad range of apoptotic stimuli, Casp9in response to dexamethasone and g irradiation.
deficiency did not protect other cell types from PCD
induced by the same inducers. For example, unlike ESCaspase 9 and Apoptosis in Response
cells, Casp92/2 thymocytes and splenocytes underwentto g Irradiation
PCD in response to UV irradiation. Casp32/2 thymocytesDefective apoptosis is a major factor in tumor formation
(Thompson, 1995). Fusion of the Bcl2 proto-oncogene and splenocytes are also sensitive to UV-induced cell
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death. Thus, it is likely that an apoptotic pathway inde- Casp3 and shown that this pathway is of particular im-
portance in the developing brain. Given the critical rolependent of both Casp9 and Casp3 exists in vivo.
that Casp9 plays in the survival of neural progenitors
within the embryonic forebrain and cortex, it will be
Caspase 9±Independent and Caspase interesting to determine whether Casp9 is involved in
3±Dependent Apoptotic Pathway controlling postnatal neuronal survival in these sites fol-
The existence of an apoptotic pathway independent of lowing injury.
Casp9 but dependent on Casp3 is suggested by the This work has also identified at least three novel physi-
response of activated T cells to a-CD95 and a-CD3e. ological apoptotic pathways: one solely dependent on
Casp3 deficiency has previously been shown to protect Casp9, another solely dependent on Casp3, and one
activated splenocytes from a-CD95± and a-CD3±induced independent of both these caspases. The existence of
apoptosis (Woo et al., 1998). However, Casp9 deficiency multiple pathways of apoptosis in mammalian cells has
did not protect activated T cells from apoptosis induced probably evolved to permit maximum flexibility in con-
by a-CD95 or a-CD3 and did not prevent Casp3 activa- trolling cell fate. The understanding of these different
tion in response to these stimuli in vivo. These data apoptotic pathways and the design of drugs that specifi-
strongly support the existence of a Casp9±independent, cally inhibit or stimulate them will assist in the treatment
Casp3±dependent apoptotic pathway. Caspases with of the many diseases related to defects in apoptosis.
large prodomains containing CARDS, such as Casp4
and -8, have been shown to associate with Apaf1 (Hu Experimental Procedures
et al., 1998). Thus, these caspases are possible candi-
dates for the activation of this apoptotic pathway. Cells
E14 K embryonic stem cells from 129/Ola mice were maintained on
a layer of mitomycin C±treated embryonic fibroblasts in ES cell
Caspase 9±Dependent and Caspase 3±Independent medium, which was Dulbecco's modified Eagle's culture medium
(DMEM), supplemented with leukemia inhibitory factor, 15% fetalApoptotic Pathway
calf serum (FCS), L-glutamine, and b-mercaptoethanol.Casp32/2 thymocytes have been shown to be sensitive
to all apoptotic stimuli tested, including dexamethasone
Generation of Caspase 92/2 Mutant Mice
and g irradiation (Kuida et al., 1996; Woo et al., 1998). A 129/J mouse genomic library was screened with a 400 bp mouse
In contrast, Casp92/2 thymocytes were resistant to PCD Casp9 cDNA probe. Two phage carrying overlapping genomic
induced by dexamethasone or g irradiation, implying clones encompassing Casp9 were isolated. A targeting vector was
designed to replace three Casp9 coding exons, including the exonthat in thymocytes these stimuli trigger the activation
encoding the active site of Casp9 with the PGKneo resistance ex-of an apoptotic pathway that is Casp3±independent but
pression cassette. This strategy introduced stop codons into allCasp9±dependent. Of importance is the finding that g
three reading frames. The targeting vector (20 mg) was linearized
irradiation preferentially activates this apoptotic path- with HpaI and electroporated into E14 K ES cells (5 3 106) (Bio-Rad
way, since Casp92/2, but not Casp32/2, thymocytes, Gene Pulser, 0.34 kV, 0.25 mF).
splenocytes, and ES cells were resistant to this apo- Electroporated cells were cultured in the presence of 300 mg/ml
of G418 (Sigma) for 10 days. Homologous recombinants were identi-ptotic signal.
fied by PCR according to standard procedures. An external primer
(59-GTA TGC TAT ACG AAG TTA TTA GTC C-39) specific for the
Casp9 gene upstream of the targeting construct and a neo primerCoexistence of Parallel Apoptotic Pathways
(59-CTT ATG TAT TCC CGA GCC CGT GGT A-39) specific for thein Mammalian Cells: Implications
neomycin resistance gene cassette were used in the PCR analysis.for Drug Design
Colonies deemed positive by PCR were genotyped by Southern
Our results lead us to propose that several apoptotic blotting using standard procedures. SpeI-digested DNA was hybrid-
pathways coexist in mammalian cells that are preferen- ized to random hexamer 32P-dCTP±labeled flanking probes (Amer-
tially activated in a cell type± and stimulus-specific man- sham). Two correctly targeted colonies were identified.
Chimeric mice were generated by microinjection of Casp91/2 ESner. In considering drug therapy, the question as to
cells into E3.5 C57BL6/J blastocysts, which were transferred to CD1whether a given apoptotic stimulus might trigger more
pseudopregnant foster mothers. Chimeric males were mated withthan one apoptotic pathway is of great importance. Our
C57BL6/J females (Jackson Laboratories). Germline transmission
findings support the possible costimulation in some of the mutant allele was verified by PCR and Southern blot analysis
cells of more than one apoptotic pathway in response of tail DNA from F1 offspring with agouti coat color. Two targeted
to a single stimulus. For example, the Casp9±dependent ES colonies successfully contributed to the germ line. F2 offspring
from heterozygous intercrosses were genotyped by PCR and South-and Casp3±independent apoptotic pathway is preferen-
ern blotting. The mutant phenotype was analyzed in 129/C57BL/6tially triggered in thymocytes in response to dexametha-
and 129/CD1 genetic backgrounds; no significant differences weresone. However, the fact that Casp3 is still processed in
observed.
dexamethasone-treated Casp92/2 thymocytes suggests
that dexamethasone also activates a Casp9±indepen- Generation of Caspase 92/2 ES Cells and Caspase 92/2;
dent and Casp3±dependent apoptotic pathway in these Rag22/2 Chimeras
Independent Casp92/2 ES clones were generated from the twocells. The role of these coexisting pathways in normal
Casp91/2 ES clones by culture in an increased concentration ofdevelopment is under investigation in Casp92/2;Casp32/2
G418 (2 mg/ml). Colonies that were resistant to this dose of G418double mutant mice.
were analyzed for homologous recombination of the second alleleIn conclusion, our results demonstrate that the re-
by PCR using primers specific for the deleted portion of the Casp9
quirement for Casp9 in apoptosis iscell type± and stimu- gene (59-CTT TGT CCC TCC TGT TGT GTC TTC A239 and 59-CAG
lus-specific. We have confirmed the existence in vivo AGC GAG AAT GAA GGG GAA ACA-39). Colonies that were homozy-
gous by PCR for the Casp9 mutation were expanded and theirof an apoptotic pathway dependent on both Casp9 and
Cell
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genotypes confirmed by Southern blot analysis. Two homozygous lead citrate and examined using a Phillips CM120 transmission elec-
tron microscope.Casp92/2 ES clones, as well as a parental clone, were injected into
3.5-day Rag22/2 blastocysts and transferred to pseudopregnant
foster mothers. Casp92/2; Rag22/2 and Casp91/2; Rag22/2 offspring
Apoptosis in MEFschimeric mice were used to study thymocyte and splenocyte apo-
MEFs derived from E15.5 embryos were prepared according to stan-ptosis in adult mice.
dard procedures. All cultures were maintained in DMEM (GIBCO)
supplemented with 5% FCS and 1% penicillin G/streptomycin sul-RNA Analysis
fate (Sigma). Cells (1 3 105) from one Casp91/2 and two Casp92/2Two micrograms of poly (A)1 RNA from E7, E11, E15, and E17 mouse
MEF cultures were plated on 24-well plates in MEF medium. At 12embryos and different adult mouse tissues were analyzed by North-
hr after the initial plating at 378C, the following cell death stimuliern blot (Clontech). Standard procedures were used to hybridize
were administered: UV irradiation at 40 or 80 mJ/cm2 using DNA-blots to the same 32P-dCTP±labeled Casp9 cDNA probe used for
Stratalinker; g irradiation at 300 or 600 rads; etoposide at 100 mM;genomic library screening.
or adriamycin at 0.3 or 3 mg/ml. Cells were harvested 24 or 48 hr
after the induction of cell death, stained with Annexin V and PI, and
Histological Analysis analyzed by flow cytometry.
Embryos at stages E10.5, E12.5, and E15.5, as well as brains from Apoptosis was also investigated in MEFs transiently transfected
postnatal day 1 mice, were isolated in ice-cold PBS, fixed overnight with the Green Fluorescein Protein expression vector (2 mg), alone
in 4% paraformaldehyde at 48C, dehydrated, and embedded in par- or in combination with TNF-R1 expression vector (2 mg), using LIPO-
affin. Five micrometers horizontal or coronal sections were cut and FECTAMINE PLUS reagents (GIBCO). Cells were trypsinized 24 hr
stained with thionin. after transfection, supernatants were collected, and cell viability (%
of fluorescent cells) was determined by FACS analysis.
BrdU Labeling Transformation of MEFs with E1A and ras was performed as pre-
BrdU (100 mg/gram of body weight) was injected intraperitoneally viously described (Woo et al., 1998). Transformed cells (3±4 3 106)
into pregnant females at E12.5 and E15.5. The females were sacri- were plated in 10 cm plates (2 plates per treatment). After 8 hr, cells
ficed 1 hr after injection, and the embryos were fixed in 4% parafor- were washed twice with PBSand treated with the indicated amounts
maldehyde at 48C overnight and processed for immunohistochemis- of adriamycin or mTNF-a (Boehringer Mannheim) in DMEM con-
try as described previously (Hakem et al., 1996). The sections were taining 10% FCS. Adherent and nonadherent cells were pooled after
incubated with an a-BrdU MAb (Boehringer Mannheim) at a 1:10 treatment, and viability was assayed by trypan blue exclusion. To
dilution. Staining was performed according to the protocol de- analyze chromatin changes in transformed wild-type and Casp92/2
scribed previously (Mishina et al., 1995). MEFs, cells were either left untreated or treated with adriamycin
(0.2 mg/ml) or mTNF-a (50 ng/ml) for 24 hr. Attached, untreated
(alive), and detached (dead) cells were stained with DAPI.TUNEL Assay
For the TUNEL assay, an ªin situ cell death detection kit º was used
(Boehringer Mannheim). Briefly, paraffin-embedded sections were
Apoptosis in Thymocytesdewaxed and rehydrated in PBS according to standard protocols.
Single cell suspensions of thymocytes were prepared and washedSections were then incubated with proteinase K (20 mg/ml in 10 mM
twice in RPMI containing 10% FCS (complete medium, CM). Thymo-Tris-HCl [pH 7.5]) for 15 min at 378C. The TUNEL reaction mixture
cytes were resuspended at 5 3 106/ml in CM and plated in a final(containing DNA polymerase as well as terminal deoxynucleotidyl
volume of 1 ml in 24-well flat bottom tissue culture plates. Thetransferase [TdT] and labeled nucleotides) was applied to the sec-
following cell death stimuli were administered: dexamethasonetions in a humidified chamber and incubated for 60 min at 378C.
(Sigma) at 0.1 mM or 1 mM; g irradiation at 300 or 600 rads; etoposideSections were then washed in PBS, mounted in ªantifadeº medium,
at 100mM; a-CD95 (Jo2, Pharmingen) at0.1 or 1 mg/ml; UV irradiationand analyzed under a fluorescence microscope.
at 40 or 80 mJ/cm2; sorbitol at 0.1 mM or 0.4 M; or heat shock at
438C for 1 hr. Treated and untreated thymocytes were cultured for 24Induction of Apoptosis in ES Cells
hr at 378C in 5% CO2, followed by harvesting, staining with Annexin VCells (1 3 105) of one Casp91/2 and two Casp92/2 ES cell clones
and PI, and FACS analysis. DAPI staining was also performed towere plated on 1% gelatinized plates (24-well plates; Costar) in ES
assess chromatin condensation.cell medium. At 12 hr after the initial plating at 378C, the following
cell death stimuli were administered: UV irradiation at 40 or 80 mJ/
cm2 using DNA-Stratalinker (Stratagene); g irradiation at 300 or 600 Measurement of Mitochondrial Membrane Potential
rads (Gammacell 40 Exactor); sorbitol at 0.1 M or 0.4 M; etoposide and Apoptotic Cells by Flow Cytometry
at 100 mM; adriamycin at 0.3 or 3 mg/ml; anisomycin at 0.05 mM; Thymocyte death was induced with 1 mM dexamethasone, and cells
or cisplatinum at 10 mg/ml (Sigma). Cells were harvested 16, 24, or were harvested 30 min prior to the experimental endpoint (3, 6, 18,
48 hr after the induction of cell death, and apoptosis was determined or 24 hr). Harvested cells were incubated in CM containing 40 nM
by FACS analysis (FACSCalibur, Becton Dickinson, San Jose, CA) 1,19,3,39,39-hexamethylindodicarbocyanine iodide [DiIC1(5)] (Molec-
using Annexin V-FITC and propidium iodide (PI) according to the ular Probes) for 30 min at 378C in 5% CO2. Cells were subsequently
manufacturer's instructions (RandD Systems). CellQuest software washed by centrifugation (800 g, 5 min), stained with Annexin V and
(BD) was used to analyze 10,000 gated events. Viable cells were PI, and analyzed by flow cytometry. Loss of Dcm was visualized
identified by their ability to exclude Annexin V and PI. For visualiza- as a reduction in the signal in FL4 as cells underwent apoptosis.
tion of chromatin condensation, cells (1 3 105) were fixed in 4% Comparison of identical samples double-stained with Annexin V and
paraformaldehyde, and DNA was stained with DAPI (1 mg/ml; Sigma). PI or triple-stained with Annexin V, PI, and DiIC1(5) showed that
The condensation state of the chromatin was visualized using a the addition of DiIC1(5) had no adverse effects on cell viability as
fluorescence microscope (Leica). Casp3 and Casp3±like activities assessed by PS residue exposure or Dcm.
were assayed using the fluorogenic caspase substrate AcDEVD-
AMC according to the manufacturer's instructions (Pharmingen).
Apoptosis of Activated Splenocytes
Splenocytes from wild-type and Casp92/2 mice were isolated andAnalysis of PCD by Electron Microscopy
Pelleted cells were resuspended in cold 3% glutaraldehyde in 0.1 cultured with plate-bound a-CD3e (10 mg/ml) for 24 hr, followed
by culture in media containing murine recombinant IL-2 (30 mg/ml;M sodium cacodylate buffer. After 48 hr in fixative, the cells were
rinsed in cacodylate buffer and postfixed in 1% aqueous osmium Genzyme) for 4 days. The activated lymphocytes were treated with
either plate-bound a-CD3e (1 or 5 mg/ml) or a-CD95 (0.1 or 1 mg/ml)tetroxide for 1 hr. Samples were rinsed and dehydrated through a
series of graded ethanol solutions prior to embedding in epoxy resin. for 24 or 48 hr. Treated cells were then analyzed for apoptosis by
Annexin V and PI staining as well as by DAPI staining.Ultrathin sections were contrast-enhanced with uranyl acetate and
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Cytochrome c Release from Mitochondria Clem, R.J., Cheng, E.H., Karp, C.L., Kirsch, D.G., Ueno, K., Taka-
hashi, A., Kastan, M.B., Griffin, D.E., Earnshaw, W.C., Veliuona M.A.,Casp92/2 and Casp91/2 ES cells (10 3 106) plated on 10 cm cell
et al. (1998). Modulation of cell death by Bcl-XL through caspaseculture dishes were either left untreated or subjected to UV irradia-
interaction. Proc. Natl. Acad. Sci. USA 95, 554±559.tion (80 mJ/cm2). Six hours after irradiation, cells were harvested by
centrifugation at 600 3 g for 10 min. Cytosolic fractions (S-100) Cohen, G.M. (1997). Caspases: the executioners of apoptosis. Bio-
were prepared from these cells as previously described (Yang et chem. J. 326, 1±16.
al., 1997). Cell pellets were washed twice with cold PBS and resus- Deckwerth, T.L., Elliott, J.L., Knudson, C.M., Johnson, E.M., Jr.,
pended in 5 vol of buffer A (20 mM HEPES-KOH [pH 7.5], 10 mM Snider, W.D., and Korsmeyer, S.J. (1996). BAX is required for neu-
KCl, 1.5 mM MgCl2, 1 mM Na EDTA, 1 mM Na EGTA, 1 mM dithi- ronal death after trophic factor deprivation and during development.
othreitol, and 0.1 mM phenylmethylsulfonyl fluoride) in the presence Neuron 17, 401±411.
of 250 mM sucrose. The cells were homogenized with 25 strokes
Deveraux, Q.L., Roy, N., Stennicke, H.R., Van Arsdale, T., Zhou,of a Teflon homogenizer, followed by two rounds of centifugation
Q., Srinivasula, S.M., Alnemri, E.S., Salvesen, G.S., and Reed, J.C.at 750 3 g for 10 min at 48C. The supernatants were then centrifuged
(1998). IAPs block apoptotic events induced by caspase-8 and cyto-
at 10,000 3 g for 15 min at 48C. The resulting supernatants were
chrome c by direct inhibition of distinct caspases. EMBO J. 17,
further centrifuged at 100,000 3 g for 1 hr at 48C. The final superna-
2215±2223.
tants were collected, aliquoted, and stored at 2708C. Cytochrome
Donehower, L.A. (1996). The p53-deficient mouse: a model for basicc was identified in the cytosolic fractions by Western blotting.
and applied cancer studies. Semin. Cancer Biol. 7, 269±278.
Duan, H., Orth, K., Chinnaiyan, A.M., Poirier, G.G., Froelich, C.J.,Western Blotting
He, W.W., and Dixit, V.M. (1996). ICE-LAP6, a novel member of theCells were lysed in 1% NP-40 lysis buffer (1% NP-40, 150 mM NaCl,
ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease50 mM Tris-HCl [pH 8.0], 1 mM sodium vanadate) supplemented
granzyme B. J. Biol. Chem. 271, 16720±16724.with protease inhibitor cocktail (0.1 mM PMSF, 2 mg/ml of leupeptin
Green, D.R., and Martin, S.J. (1995). The killer and the executioner:and apoprotein) for 15 min on ice. Lysates werecentrifuged at 10,000
how apoptosis controls malignancy. Curr. Opin. Immunol. 7,rpm for 5 min at 48C, and protein concentration was estimated
694±703.by the Pierce Protein Assay, using BSA as the standard. Thirty
micrograms of total protein was loaded onto 10% or 14% SDS-PAGE, Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem,
transferred onto nitrocellulose membranes, and incubated with the A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996). The
appropriate antibodies. Antibodies reactive to Casp3 (gift of R. Sek- tumor suppressor gene Brca1 is required for embryonic cellular
aly, Montreal), Casp2 and -7 (Santa Cruz), Casp8 and -9 (generated proliferation in the mouse. Cell 85, 1009±1023.
against Casp8 peptide SNKDDRRNKGKQMPC and Casp9 peptide Hengartner, M.O. (1996). Programmed cell death in invertebrates.
SQGRTLDSDSEPDAVPYQEGPRPC), PARP (Boehringer Mannheim), Curr. Opin. Genet. Dev. 6, 34±38.
Rb (G3-245, Pharmingen), cytochrome c (7H8.2C12, Pharmingen),
Hu, Y., Benedict, M.A., Wu, D., Inohara, N., andNunez, G. (1998). Bcl-
or anti-b actin (Sigma) were used in this study. Western blot analysis XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9
was carried out according to standard procedures using ECL detec- activation. Proc. Natl. Acad. Sci. USA 95, 4386±4391.
tion (Amersham).
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